These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 12825169

  • 1. Identification of CD8+ T cell epitopes in the immediate early 62 protein (IE62) of varicella-zoster virus, and evaluation of frequency of CD8+ T cell response to IE62, by use of IE62 peptides after varicella vaccination.
    Frey CR, Sharp MA, Min AS, Schmid DS, Loparev V, Arvin AM.
    J Infect Dis; 2003 Jul 01; 188(1):40-52. PubMed ID: 12825169
    [Abstract] [Full Text] [Related]

  • 2. Comparison of primary sensitization of naive human T cells to varicella-zoster virus peptides by dendritic cells in vitro with responses elicited in vivo by varicella vaccination.
    Jenkins DE, Yasukawa LL, Bergen R, Benike C, Engleman EG, Arvin AM.
    J Immunol; 1999 Jan 01; 162(1):560-7. PubMed ID: 9886433
    [Abstract] [Full Text] [Related]

  • 3. Equivalent recognition of a varicella-zoster virus immediate early protein (IE62) and glycoprotein I by cytotoxic T lymphocytes of either CD4+ or CD8+ phenotype.
    Arvin AM, Sharp M, Smith S, Koropchak CM, Diaz PS, Kinchington P, Ruyechan W, Hay J.
    J Immunol; 1991 Jan 01; 146(1):257-64. PubMed ID: 1670603
    [Abstract] [Full Text] [Related]

  • 4. Human T cells recognize multiple epitopes of an immediate early/tegument protein (IE62) and glycoprotein I of varicella zoster virus.
    Bergen RE, Sharp M, Sanchez A, Judd AK, Arvin AM.
    Viral Immunol; 1991 Jan 01; 4(3):151-66. PubMed ID: 1725699
    [Abstract] [Full Text] [Related]

  • 5. Recognition of the latency-associated immediate early protein IE63 of varicella-zoster virus by human memory T lymphocytes.
    Sadzot-Delvaux C, Kinchington PR, Debrus S, Rentier B, Arvin AM.
    J Immunol; 1997 Sep 15; 159(6):2802-6. PubMed ID: 9300702
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Functional characterization of ocular-derived human alphaherpesvirus cross-reactive CD4 T cells.
    Ouwendijk WJ, Geluk A, Smits SL, Getu S, Osterhaus AD, Verjans GM.
    J Immunol; 2014 Apr 15; 192(8):3730-9. PubMed ID: 24623134
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Identification of varicella-zoster virus-specific CD8 T cells in patients after T-cell-depleted allogeneic stem cell transplantation.
    van der Heiden PL, de Boer R, van der Steen DM, Kester MG, van der Hoorn MW, Haarman WM, Barnby-Porritt HE, Fry JW, Napper CE, Marijt EW, Willemze R, Falkenburg JH, Heemskerk MH.
    J Virol; 2009 Jul 15; 83(14):7361-4. PubMed ID: 19386715
    [Abstract] [Full Text] [Related]

  • 12. Use of a lentiviral vector encoding a HCMV-chimeric IE1-pp65 protein for epitope identification in HLA-Transgenic mice and for ex vivo stimulation and expansion of CD8(+) cytotoxic T cells from human peripheral blood cells.
    Rohrlich PS, Cardinaud S, Lulè J, Montero-Julian FA, Prodhomme V, Firat H, Davignon JL, Perret E, Monseaux S, Necker A, Michelson S, Lemonnier FA, Charneau P, Davrinche C.
    Hum Immunol; 2004 May 15; 65(5):514-22. PubMed ID: 15172452
    [Abstract] [Full Text] [Related]

  • 13. T lymphocyte cytotoxicity with natural varicella-zoster virus infection and after immunization with live attenuated varicella vaccine.
    Diaz PS, Smith S, Hunter E, Arvin AM.
    J Immunol; 1989 Jan 15; 142(2):636-41. PubMed ID: 2536059
    [Abstract] [Full Text] [Related]

  • 14. Loss of varicella zoster virus antibodies despite detectable cell mediated immunity after vaccination.
    Ludwig B, Kraus FB, Allwinn R, Keim S, Doerr HW, Buxbaum S.
    Infection; 2006 Aug 15; 34(4):222-6. PubMed ID: 16896582
    [Abstract] [Full Text] [Related]

  • 15. Frequency of CD8(+) T lymphocytes specific for lytic and latent antigens of Epstein-Barr virus in healthy virus carriers.
    Benninger-Döring G, Pepperl S, Deml L, Modrow S, Wolf H, Jilg W.
    Virology; 1999 Nov 25; 264(2):289-97. PubMed ID: 10562493
    [Abstract] [Full Text] [Related]

  • 16. Physical interaction between two varicella zoster virus gene regulatory proteins, IE4 and IE62.
    Spengler ML, Ruyechan WT, Hay J.
    Virology; 2000 Jul 05; 272(2):375-81. PubMed ID: 10873781
    [Abstract] [Full Text] [Related]

  • 17. Phenotypic and functional analysis of EBV-specific memory CD8 cells in SLE.
    Berner BR, Tary-Lehmann M, Yonkers NL, Askari AD, Lehmann PV, Anthony DD.
    Cell Immunol; 2005 May 05; 235(1):29-38. PubMed ID: 16181618
    [Abstract] [Full Text] [Related]

  • 18. Antigen-shift in varicella-zoster virus-specific T-cell immunity over the course of Fingolimod-treatment in relapse-remitting multiple sclerosis patients.
    Matko S, Akgün K, Tonn T, Ziemssen T, Odendahl M.
    Mult Scler Relat Disord; 2020 Feb 05; 38():101859. PubMed ID: 31855843
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Impact of high-dose chemotherapy on antigen-specific T cell immunity in breast cancer patients. Application of new flow cytometric method.
    Svane IM, Nikolajsen K, Hansen SW, Kamby C, Nielsen DL, Johnsen HE.
    Bone Marrow Transplant; 2002 Apr 05; 29(8):659-66. PubMed ID: 12180110
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.